Short answer
Schrodinger, Inc. (SDGR) filed its Q3 2026 10-Q quarterly report on Nov 4, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $64M (up 18.7% year over year) with net income of −$38M.
Q3 2026 key financials · XBRL
- Revenue
- $64M
- +18.7% YoY · +9.5% QoQ
- Net income
- −$38M
- −15.0% YoY · −731.1% QoQ
- Operating margin
- -40.5%
- Gross margin
- 59.3%
- EPS (diluted)
- −$0.50
- −13.6% YoY · −725.0% QoQ
Source: XBRL data from the Schrodinger, Inc. (SDGR) Q3 2026 10-Q on SEC EDGAR. USD.
Schrodinger, Inc. Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $64.491M, up 19% YoY from $54.324M
- Operating loss $26.129M vs $45.947M, operating margin -40.5% vs -84.6%
- Drug discovery best segment, revenue $24.187M, up 86%; contribution worst, $2.151M, down 60%
- Cash and equivalents, restricted cash, and securities $373.4M; nine-month operating cash outflow $96.482M vs $29.992M inflow
- Near-term revenue headwind from hosted-software transition, with management expecting revenue to decline as recognition shifts over contract terms
Risk Factors
- Newly added AI risk: rapid regulation, data leakage, bias, and third-party intellectual-property claims affecting Bunsen and platform deployment
- Most material update, hosted-software transition: near-term revenue decline as recognition shifts from upfront on-premise sales to contract-term recognition
- Regulatory risk, clinical diversity plans: uncertainty after FDA draft guidance removal, court-ordered restoration, and unresolved marketing-application requirements
- Operational risk, AI competition: AlphaFold3, Chai-3, Boltz-2, and OpenFold could reduce demand for Schrödinger’s platform
- Financial risk, operating losses: $37.7 million quarterly net loss and $720.6 million accumulated deficit despite $373.4 million in liquidity
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Schrodinger, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.